viral-load

Documents about viral-load

• Assessing the association between depression and viral load suppression among adolescents and youth living with HIV (15–24 years) in Malawi: Insights from Malawi Population-based HIV Impact Assessment (MPHIA) 2020–2021 survey#631381OpenUCT
• A Study of HIV Levels During Pregnancy and After Childbirth#873774ClinicalTrials.gov
• HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)#909400ClinicalTrials.gov
• Assessment of the Impact of Oral Intervention With Cetylpyridinium Chloride to Decrease SARS-CoV-2 Viral Load in Patients With COVID-19#1008586ClinicalTrials.gov
• Challenges in accurate HDV RNA quantification: inter-assay variability and the impact of thermal shock.#316340Repisalud
• Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)#801714ClinicalTrials.gov
• The Safety and Effectiveness of (+)-Calanolide A in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs#863314ClinicalTrials.gov
• Trends in frequency of HIV viral load and CD4 cell count monitoring among Asian cohort of adults with HIV: an analysis of the TREAT Asia HIV Observational Database, 2003-2018#130516Unpaywall
• Étude des facteurs de transmission des pathogènes infectieux par le couplage des échelles de modélisation : de l'intra-hôte aux ménages#147626HAL (France)
• A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3#811169ClinicalTrials.gov
• Guidelines for HIV diagnosis and monitoring of antiretroviral therapy#627348WHO IRIS
• Gabapentin to achieve HIV viral load suppression in people with risky drinking in Mbarara, Uganda: study protocol for a randomized, double-blinded, placebo-controlled trial (GRAIL)#485205Europe PMC
• Long-Term Patterns in CD4 Response Are Determined by an Interaction Between Baseline CD4 Cell Count, Viral Load, and Time: The Asia Pacific HIV Observational Database (APHOD)#445546Griffith Research Online
• Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)#872610ClinicalTrials.gov
• A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients#900756ClinicalTrials.gov
• Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir#915121ClinicalTrials.gov
• A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments#844465ClinicalTrials.gov
• Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients#801925ClinicalTrials.gov
• A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir#837945ClinicalTrials.gov
• The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors#982777ClinicalTrials.gov
• Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy#836882ClinicalTrials.gov
• Effect of Anti-HIV Therapy (HAART) on HIV Levels in the Lungs and on Lung Cell Inflammation in HIV-Infected Patients#870265ClinicalTrials.gov
• A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients#812872ClinicalTrials.gov
• Assessing the effects of the COVID-19 pandemic on new ART initiation and viral load access among children and adolescents living with HIV in West Africa: an interrupted time series analysis#153635HAL (France)
• The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs#838354ClinicalTrials.gov
• A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs#898005ClinicalTrials.gov
• Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs#828540ClinicalTrials.gov
• The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children#910258ClinicalTrials.gov
• Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections#914695ClinicalTrials.gov
• A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation#885469ClinicalTrials.gov
• Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients#846251ClinicalTrials.gov
• Short Communication: Higher Tenofovir Concentrations in Hair Are Associated with Decreases in Viral Load and Not Self-Reported Adherence in HIV-Infected Adolescents with Second-Line Virological Treatment Failure#619890eScholarship
• Module pour l'évaluation et le renforcement de la qualité des donnés sur la mesure de la charge virale dans le cadre des programmes de lutte contre le VIH et des systèmes de suivi des patients : annexe web C : service de brève durée de mesure de la charge virale dans les établissements cliniques et outil d'évaluation de la qualité des données#451021WHO IRIS